Novozymes
kr 413.00Change from previous close: −1.55%Absolute change: −kr 6.50
At a glance
- Revenue growth
- +8.45%
- 2025 vs 2024
- Net income growth
- +90.84%
- 2025 vs 2024
- Net margin
- 14.0%
- 2024: 8.0%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 4,158 | 3,834 | 2,402 | 2,360 | 2,011 |
| Cost of revenue | 1,852 | 1,840 | 1,097 | 1,071 | 849 |
| Gross profit | 2,305 | 1,993 | 1,305 | 1,289 | 1,162 |
| Selling, general and administrative | 912 | 766 | 446 | 433 | 376 |
| Research and development | 449 | 413 | 271 | 267 | 267 |
| Operating income | 962 | 843 | 611 | 602 | 524 |
| EBIT | 962 | 843 | 611 | 602 | 524 |
| EBITDA | 1,537 | 1,387 | 797 | 769 | 681 |
| Interest expense | 68.3 | 76.4 | 6.5 | 13.7 | 13.7 |
| Pre-tax income | 743 | 417 | 525 | 613 | 528 |
| Income tax | 160 | 111 | 117 | 117 | 105 |
| Net income | 584 | 306 | 406 | 494 | 423 |
| Net income to common shareholders | 584 | 306 | 406 | 494 | 423 |
| Basic EPS | 1.25 | 1.10 | 1.47 | 1.79 | 1.52 |
| Diluted EPS | 1.25 | 0.67 | 1.46 | 1.77 | 1.51 |
| Average shares (basic) | 467 | 278 | 276 | 277 | 278 |
| Average shares (diluted) | 467 | 278 | 278 | 279 | 280 |
| Dividend per share | 0.87 | 0.83 | — | 0.81 | 0.74 |